Special Issue "Challenges and Advances in Vaccines against Emerging and Re-emerging Diseases Impacting One Health"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (20 June 2023) | Viewed by 7834
Interests: vaccine development against dairy mastitis pathogens; resistance modulation of multiple drug resistant bacteria by plant extracts, nanoparticles, and NSAIDS
Interests: vaccines against infectious diseases; molecular biology; virology; bacteriology; mycology
Interests: establishment of the next-generation vaccines and immunobiology for respiratory viral infectious diseases; influenza; COVID-19; small laboratory animal models
2. Research Assistant, School of Public Health, The University of Hong Kong, Hong Kong, China
Interests: the development of vaccines against infectious animal and human diseases; evaluation of immune responses; animal models
We are pleased to invite contributions to a Special Issue of the journal Vaccines, entitled “Challenges and Advances in Vaccines against Emerging and Re-emerging Diseases Impacting One Health”. Vaccines is an interdisciplinary, peer-reviewed, open-access journal on public health. More information about the journal can be found at https://www.mdpi.com/journal/vaccines.
One health is concise concept to optimize health on this planet by taking care of animals, humans, and the environment. Infectious agents constantly infect all three key tiers of one health, while remedies control their impacts. Vaccines have always been the hope at mass level, although challenges run side by side. Vaccine failures and the advent of new disease or modified forms of disease require comprehensive analyses, exploring the deep lying issues. Hence, it is of great interest to gain knowledge on the challenges and advances in finding vaccines for veterinary and public health in terms of the formulation, production, application, field trials, failures, successes, issues, and economic impacts on animals, humans, and the environment. Outbreaks of lumpy skin virus, West Nile virus, monkeypox virus, rabies virus Leptospira, foot and mouth disease virus, avian influenza virus, Staphylococcus, and animal-side Pasteurella are common. On the other hand, COVID-19, Zika virus, Ebola virus, polio virus, and etiologies of measles, pneumonia, hepatitis, chicken, human papilloma, etc., occur on the human side. We are focusing on exploring the underlying mechanisms and root causes for obstacles as well as advances that can further help improve one health. Topics of interests should encompass molecular mechanisms that trigger protective immune responses from immunization and evaluating the contribution of adjuvants and immunomodulatory molecules to vaccine immunogenicity and induction of long-lasting immunological memory.
This Special Issue covers all the possible contemporary challenges being faced in relation to vaccines of both animals and humans and their relationship with health, environmental, and economic impacts. Advances such as nanotechnology, the use of subunit vaccines, and cutting-edge techniques for the better formulation of successful vaccines will also form a salient part of this Special Issue.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Root causes of failure of veterinary vaccines in field applications;
- Underlying facts highlighting challenges to human vaccines;
- Vaccines against re-emerging diseases of veterinary and public health;
- Vaccines against novel pandemics/epidemics such as COVID-19, lumpy skin disease, monkey pox, etc.;
- Economic impacts of vaccines;
- The role of nanotechnology and other cutting-edge techniques in vaccine development;
- Adverse impacts of vaccines;
- Response of public against vaccination in different parts of the world;
- Role of applied techniques such as epidemiological and statistical models in the success of vaccines.
We look forward to receiving your contributions.
Dr. Amjad Islam Aqib
Prof. Dr. Aftab Ahmad Anjum
Dr. Md Atiqul Islam
Dr. Asad Murtaza
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- one health
- molecular and biotechnological techniques
- economic and public health